Non-proprietary Name
NDC Package 85551-122-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Non-proprietary Name is levocarnitine Injection is contraindicated in:Patients with known hypersensitivity to Levocarnitine, benzyl alcohol, or any component of the formulation. Marketed by Xseer Pharmaceuticals, this product is identified by NDC 85551-122.

Identification & Billing

NDC Package Code
85551-122-30
Package Description
30 mL in 1 VIAL, GLASS
Product Code
85551-122
11-Digit Billing Format
85551012230

Clinical Specifications

Proprietary Name
Non-proprietary Name
Dosage Form
-
Usage Information
Levocarnitine Injection is contraindicated in:Patients with known hypersensitivity to Levocarnitine, benzyl alcohol, or any component of the formulation. Neonates, premature infants, or low birth weight infants due to the risk of benzyl alcohol toxicity (“gasping syndrome”). Patients with a history of serious hypersensitivity reactions associated with Levocarnitine administration. Patients in whom administration of hypertonic intravenous solutions may result in clinically significant complications unless closely monitored by a healthcare professional.

Regulatory & Marketing

Labeler Name
Xseer Pharmaceuticals
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-01-2026
End Marketing Date
06-01-2026
Listing Expiration
06-01-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85551-122-30 identifies a specific commercial package of 30 ml in 1 vial, glass of Non-proprietary Name, labeled by Xseer Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Xseer Pharmaceuticals on June 01, 2026. The current certification is valid through June 01, 2026.

How is this Xseer Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85551012230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85551-122-30
11-Digit CMS (5-4-2)
85551-0122-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.